Sarepta's CMT therapy - not a "different sub-type" .... | SRPT Message Board Posts

Sarepta Therapeutics Inc.

  SRPT website

SRPT   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  13937 of 14065  at  9/10/2019 1:43:08 PM  by


The following message was updated on 9/10/2019 1:48:48 PM.

Sarepta's CMT therapy - not a "different sub-type" ....

...rather a substitute created protein that does the CMT protein's job ... as well as a whole lot more - it can tackle a whole lot of other, more common, conditions, as I recall.

Just like our GALGT2 program. They (CMT and GALGT2) "officially" target one named disease, but actually target a slew. And, parenthetically, this could be what we come up with with the contributions that could be coming from our Florida colleagues. For example, a combo therapy for Parkinson's, Alzheimer's and a bunch of other related things - all handled by the same or a very similar combo therapy.

So, a lot of greenhorn biotechs are popping up out of nowhere (like this CMT one called Passages Biotech or some such) with a GT therapy for a sub-type of Whatever - where one exon is at fault and they fix it (like our various LGMD things).

And then there are the long-time players in the field of genetic medicine (Sarepta comes to mind) who can see more clever - elegant - things that can be done and that will kill MANY different "birds" with one silver (or Gold) bullet and/or stone.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 173
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by